Fresenius Kabi Gets Ready To Launch Europe’s First Tocilizumab Rival

Biosimilar Version Of RoActemra Receives Formal European Commission Approval

 
• By David Wallace
  
Tocilizumab_Injections
Fresenius Kabi gets European approval for a RoActemra biosimilar

More from Biosimilars

More from Products